Mpl Expression on AML Blasts Predicts Cytopenia
نویسندگان
چکیده
منابع مشابه
Granulopoietic differentiation in AML blasts in culture.
A newly described monoclonal antibody detected an antigen (My-1) that is expressed on the cell surface during normal granulopoietic differentiation. The kinetics of expression of My-1 and NASD chloracetate esterase were studied during the formation in culture of blast colonies and normal granulopoietic colonies. My-1-positive cells increased during blast colony formation in 6 of 9 experiments, ...
متن کاملHigh Tim-3 expression on AML blasts could enhance chemotherapy sensitivity
T-cell immunoglobulin and mucin domain-containing molecule3 (Tim-3) represents a novel mechanism of T-cell dysfunction and exhaustion. Tim-3 has also been identified in various solid tumors. However, the role of Tim-3 expression on blast cells in acute myeloid leukemia (AML) is not well understood. In this study, we aimed to explore the role of Tim-3 in patients with de novo AML, and the correl...
متن کاملDeoxycytidine kinase expression in AML blasts and its relationship to leukemia-free and overall survival
s / Porto Biomed. J. 2017;2(5):176–246 215 41.9%, and the frequency of the aforementioned allele amongst the control group was 34.5%. Conclusion: The results of this study show that there is no statistically significant correlation between MTHFR C677T polymorphism in women with infertility of unknown cause, who are undergoing in vitro fertilization preparation, but also underline the need for f...
متن کاملEffect of diagnosis (refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, or acute myeloid leukemia [AML]) on outcome of AML-type chemotherapy.
In current medical practice, patients with refractory anemia with excess blasts in transformation (RAEB-t), and especially patients with RAEB, receive chemotherapy regimens (AML Rx) administered to patients with acute myeloid leukemia (AML) less often than do patients with AML. These entities are distinguished primarily by marrow blast percentage (5% to 19% RAEB, 20% to 29% RAEB-t, and > or = 3...
متن کاملClass II-associated invariant chain peptide expression on myeloid leukemic blasts predicts poor clinical outcome.
Effective antitumor responses need the activation of CD4+ T cells. MHC class II antigen presentation requires the release of class II-associated invariant chain peptide (CLIP) from the antigen-binding site. In antigen-presenting cells, human leukocyte antigen DM (HLA-DM; abbreviated DM in this article) catalyzes CLIP dissociation. In B cells, HLA-DO (DO) down-modulates DM function. Cell surface...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Blood
سال: 2015
ISSN: 0006-4971,1528-0020
DOI: 10.1182/blood.v126.23.1387.1387